Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pTwist-SARS-CoV-2 Δ18 K417N+E484K+N501Y
(Plasmid #169469)


Item Catalog # Description Quantity Price (USD)
Plasmid 169469 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
  • Vector type
    Mammalian Expression

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
  • Copy number


  • Gene/Insert name
    SARS-CoV-2 K417N+E484K+N501Y Spike truncated to remove 18 amino acids
  • Entrez Gene
    S (a.k.a. GU280_gp02, spike glycoprotein)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pTwist-SARS-CoV-2 Δ18 K417N+E484K+N501Y was a gift from Alejandro Balazs (Addgene plasmid # 169469 ; ; RRID:Addgene_169469)
  • For your References section:

    Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Garcia-Beltran WF, Lam EC, St Denis K, Nitido AD, Garcia ZH, Hauser BM, Feldman J, Pavlovic MN, Gregory DJ, Poznansky MC, Sigal A, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB. Cell. 2021 Mar 12. pii: S0092-8674(21)00298-1. doi: 10.1016/j.cell.2021.03.013. 10.1016/j.cell.2021.03.013 PubMed 33743213